Menu
Back to User profile » Dr Chuansheng Zheng
Papers published by Dr Chuansheng Zheng:
Synergistic Effects of Nanoscale CaO2 Combined with PD-1 Inhibitors in the Treatment of Hepatocellular Carcinoma: A Promising Combination
Wang Y, Ju S, Zhou H, Bai Y, Zhou C, Liu J, Dong X, Zheng C
International Journal of Nanomedicine 2024, 19:137-154
Published Date: 5 January 2024
Safety and Effectiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Aged Greater versus Less Than 80 Years
Zhang L, Hong W, Wang Z, Zheng C, Liang B, Shi H
Clinical Interventions in Aging 2023, 18:1883-1892
Published Date: 14 November 2023
The Feasibility of TACE Combined with TKIs Plus PD-1 Antibody for Advanced HCC
Sun T, Ren Y, Sun B, Chen L, Zhu L, Zhang L, Zheng C
Journal of Hepatocellular Carcinoma 2023, 10:447-457
Published Date: 16 March 2023
Effect of Transarterial Chemoembolization Plus Percutaneous Ethanol Injection or Radiofrequency Ablation for Liver Tumors
Chen L, Zhang W, Sun T, Ren Y, Sun B, Zhu L, Zhao H, Zheng C
Journal of Hepatocellular Carcinoma 2022, 9:783-797
Published Date: 12 August 2022
EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma
Chen Q, Li Y, Cheng Q, Van Valkenburgh J, Sun X, Zheng C, Zhang R, Yuan R
OncoTargets and Therapy 2022, 15:597-608
Published Date: 30 May 2022
An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation
Guo Y, Ren Y, Dong X, Kan X, Zheng C
Journal of Hepatocellular Carcinoma 2022, 9:343-355
Published Date: 26 April 2022
Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
Zhang W, Chen L, Cao Y, Sun B, Ren Y, Sun T, Zheng C
Cancer Management and Research 2021, 13:5391-5402
Published Date: 6 July 2021
Caudate Lobe Hepatocellular Carcinoma Treated with Sequential Transarterial Chemoembolization and Iodine 125 Seeds Implantation: A Single-Center Retrospective Study
Yan L, Chen L, Qian K, Kan X, Zhang H, Liang B, Zheng C
Cancer Management and Research 2021, 13:3901-3912
Published Date: 13 May 2021
Improved ADM Penetration Distance and Therapeutic Efficiency in a Rabbit VX2 Liver Cancer Model by Relaxin Infusion Combined with Transcatheter Chemoembolization Through Hepatic Artery
Xiong F, Cao Y, Guo X, Zhang H, Wang J, Xiong B, Liang B, Zheng C
Cancer Management and Research 2020, 12:3379-3388
Published Date: 13 May 2020
Comparison of chemoembolization with CalliSpheres® microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study
Liang B, Xiang H, Ma C, Xiong B, Ma Y, Zhao C, Yao Y, Zhang Z, Chen C, Li H, Long Q, Zhou J, Luo C, Qiu H, Hu H, Zhao H, Zhou G, Zheng C
Cancer Management and Research 2020, 12:941-956
Published Date: 10 February 2020
Combined ultrasound/computed tomography guidance in percutaneous radiofrequency ablation after transarterial chemoembolization for hepatocellular carcinoma in the hepatic dome
Kan X, Wang Y, Han P, Yao Q, Qian K, Xiong B, Zheng C
Cancer Management and Research 2019, 11:7751-7757
Published Date: 15 August 2019
Transcatheter arterial embolization combined with hypoxia-replicative oncolytic adenovirus perfusion enhances the therapeutic effect of hepatic carcinoma
Zhang H, Xiong F, Qian K, Liu Y, Liang B, Xiong B, Yang F, Zheng C
Cancer Management and Research 2019, 11:981-996
Published Date: 23 January 2019
Transcatheter arterial embolization combined with radiofrequency ablation activates CD8+ T-cell infiltration surrounding residual tumors in the rabbit VX2 liver tumors
Duan XH, Li TF, Zhou GF, Han XW, Zheng CS, Chen PF, Feng GS
OncoTargets and Therapy 2016, 9:2835-2844
Published Date: 17 May 2016